Home › Funds › Two Sigma Investments › ANTX
Two Sigma Investments position in ANTX
AN2 THERAPEUTICS INC · Health Care
Latest position (Q2 2026)15.91K sh
Reported value held$77.02K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 19.25K | $394.39K | New |
| Q1 2024 | 94.17K | $306.05K | Add |
| Q2 2024 | 132.09K | $283.99K | Add |
| Q3 2024 | 177.84K | $190.29K | Add |
| Q4 2024 | 400.33K | $552.46K | Add |
| Q1 2025 | 343.96K | $467.79K | Reduce |
| Q2 2025 | 238.35K | $252.65K | Reduce |
| Q3 2025 | 223.34K | $283.64K | Reduce |
| Q4 2025 | 178.52K | $203.51K | Reduce |
| Q2 2026 | 15.91K | $77.02K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANTX
- Millennium Management 2.32M sh · $11.22M · Q2 2026
- BlackRock Inc 1.67M sh · $8.06M · Q2 2026
- Citadel Advisors 952.00K sh · $4.61M · Q2 2026
- Geode Capital Management 697.81K sh · $3.38M · Q2 2026
- Balyasny Asset Management 556.03K sh · $2.69M · Q2 2026
- Vanguard Group 1.08M sh · $1.23M · Q4 2025
- Northern Trust Corp 214.92K sh · $1.04M · Q2 2026
- Bank of America Corp 145.80K sh · $705.69K · Q2 2026
- Renaissance Technologies 129.70K sh · $627.75K · Q2 2026
- Goldman Sachs Group 87.93K sh · $425.60K · Q2 2026
- UBS Group AG 74.09K sh · $358.58K · Q2 2026
- BNY Mellon 67.68K sh · $327.55K · Q2 2026